Trial Profile
Prospective Randomized Study for the Evaluation of Controlled Ovarian Stimulation With Corifollitropin Alpha in Patients With Expected or Poor Ovarian Response in IVF Cycles
Status:
Completed
Phase of Trial:
Phase III
Latest Information Update: 07 Nov 2021
Price :
$35
*
At a glance
- Drugs Corifollitropin alfa (Primary) ; Menotropin
- Indications Female infertility; Ovulation disorders
- Focus Therapeutic Use
- Acronyms POR-ELONVA
- 09 Jun 2017 Status changed from recruiting to completed.
- 07 Jun 2017 Planned End Date changed from 1 Apr 2017 to 1 Sep 2017.
- 07 Jun 2017 Planned primary completion date changed from 1 Jan 2017 to 1 Sep 2017.